LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 2 of total 2

Search options

  1. Article ; Online: Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.

    Ghazanfari, Tooba / Salehi, Mohammad Reza / Namaki, Saeed / Arabkheradmand, Jalil / Rostamian, Abdolrahman / Rajabnia Chenary, Maryam / Ghaffarpour, Sara / Kaboudanian Ardestani, Sussan / Edalatifard, Maryam / Naghizadeh, Mohammad Mehdi / Mohammadi, Saeed / Mahloujirad, Maryam / Izadi, Alireza / Ghanaati, Hossein / Beigmohammadi, Mohammad Taghi / Vodjgani, Mohammad / Mohammad Shirazi, Bentolhoda / Mirsharif, Ensie Sadat / Abdollahi, Alireza /
    Mohammadi, Mostafa / Emadi Kouchak, Hamid / Dehghan Manshadi, Seyed Ali / Zamani, Mohammad Saber / Mahmoodi Aliabadi, Maedeh / Jamali, Davoud / Khajavirad, Nasim / Mohseni Majd, Ali Mohammad / Nasiri, Zahra / Faghihzadeh, Soghrat

    Iranian journal of allergy, asthma, and immunology

    2021  Volume 20, Issue 1, Page(s) 46–66

    Abstract: ... severity and mortality associated biomarkers. Ninety-three hospitalized patients with confirmed coronavirus ... hematological, immunological, and inflammatory mediators were assessed, and their association with severity and ... disease 2019 (COVID-19) were classified based on disease severity. The levels of biochemical ...

    Abstract The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spread rapidly all over the world in late 2019 and caused critical illness and death in some infected patients. This study aimed at examining several laboratory factors, especially inflammatory and immunological mediators, to identify severity and mortality associated biomarkers. Ninety-three hospitalized patients with confirmed coronavirus disease 2019 (COVID-19) were classified based on disease severity. The levels of biochemical, hematological, immunological, and inflammatory mediators were assessed, and their association with severity and mortality were evaluated. Hospitalized patients were mostly men (77.4%) with an average (standard deviation) age of 59.14 (14.81) years. The mortality rate was significantly higher in critical patients (85.7%). Increased serum levels of blood sugar, urea, creatinine, uric acid, phosphorus, total bilirubin, serum glutamic-oxaloacetic transaminase, serum glutamic-oxaloacetic transaminase, lactic dehydrogenase, C-reactive protein, ferritin, and procalcitonin were significantly prevalent (p=0.002, p<0.001, p<0.001, p=0.014, p=0.047, p=0.003, p<0.001, p<0.001, p<0.001, p<0.001, P<0.001, and p<0.001, respectively) in COVID-19 patients. Decreased red blood cell, hemoglobin, and hematocrit were significantly prevalent among COVID-19 patients than healthy control subjects (p<0.001 for all). Troponin-I, interleukin-6, neutrophil/lymphocyte ratio (NLR), procalcitonin, and D-dimer showed a significant association with the mortality of patients with specificity and sensitivity more than 60%. Age, sex, underlying diseases, blood oxygen pressure, complete blood count along with C-reactive protein, lactic dehydrogenase, procalcitonin, D-dimer, and interleukin-6 evaluation help to predict the severity and required management for COVID-19 patients. Further investigations are highly recommended in a larger cohort study for validation of the present findings.
    MeSH term(s) Biomarkers/metabolism ; C-Reactive Protein/metabolism ; COVID-19/diagnosis ; COVID-19/mortality ; Cohort Studies ; Disease Progression ; Female ; Fibrin Fibrinogen Degradation Products/metabolism ; Humans ; Lymphocyte Count ; Male ; Middle Aged ; Neutrophils/immunology ; SARS-CoV-2/physiology ; Severity of Illness Index ; Survival Analysis
    Chemical Substances Biomarkers ; Fibrin Fibrinogen Degradation Products ; fibrin fragment D ; C-Reactive Protein (9007-41-4)
    Language English
    Publishing date 2021-02-11
    Publishing country Iran
    Document type Journal Article
    ZDB-ID 2488724-9
    ISSN 1735-5249 ; 1735-1502
    ISSN (online) 1735-5249
    ISSN 1735-1502
    DOI 10.18502/ijaai.v20i1.5412
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease

    Tooba Ghazanfari / Mohammad Reza Salehi / Saeed Namaki / Jalil Arabkheradmand / Abdolrahman Rostamian / Maryam Rajabnia Chenary / Sara Ghaffarpour / Sussan Kaboudanian Ardestani / Maryam Edalatifard / Mohammad Mehdi Naghizadeh / Saeed Mohammadi / Maryam Mahloujirad / Alireza Izadi / Hossein Ghanaati / Mohammad Taghi Beigmohammadi / Mohammad Vodjgani / Bentolhoda Mohammad Shirazi / Ensie Sadat Mirsharif / Alireza Abdollahi /
    Mostafa Mohammadi / Hamid Emadi Kouchak / Seyed Ali Dehghan Manshadi / Mohammad Saber Zamani / Maedeh Mahmoodi Aliabadi / Davoud Jamali / Nasim Khajavirad / Ali Mohammad Mohseni Majd / Zahra Nasiri / Soghrat Faghihzadeh

    Iranian Journal of Allergy, Asthma and Immunology, Vol 20, Iss

    Biomarkers Associated with Severity and Mortality

    2021  Volume 1

    Abstract: ... severity and mortality associated biomarkers. Ninety-three hospitalized patients with confirmed coronavirus ... hematological, immunological, and inflammatory mediators were assessed, and their association with severity and ... disease 2019 (COVID-19) were classified based on disease severity. The levels of biochemical ...

    Abstract The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) spread rapidly all over the world in late 2019 and caused critical illness and death in some infected patients. This study aimed at examining several laboratory factors, especially inflammatory and immunological mediators, to identify severity and mortality associated biomarkers. Ninety-three hospitalized patients with confirmed coronavirus disease 2019 (COVID-19) were classified based on disease severity. The levels of biochemical, hematological, immunological, and inflammatory mediators were assessed, and their association with severity and mortality were evaluated. Hospitalized patients were mostly men (77.4%) with an average (standard deviation) age of 59.14 (14.81) years. The mortality rate was significantly higher in critical patients (85.7%). Increased serum levels of blood sugar, urea, creatinine, uric acid, phosphorus, total bilirubin, serum glutamic-oxaloacetic transaminase, serum glutamic-oxaloacetic transaminase, lactic dehydrogenase, C-reactive protein, ferritin, and procalcitonin were significantly prevalent (p=0.002, p<0.001, p<0.001, p=0.014, p=0.047, p=0.003, p<0.001, p<0.001, p<0.001, p<0.001, P<0.001, and p<0.001, respectively) in COVID-19 patients. Decreased red blood cell, hemoglobin, and hematocrit were significantly prevalent among COVID-19 patients than healthy control subjects (p<0.001 for all). Troponin-I, interleukin-6, neutrophil/lymphocyte ratio (NLR), procalcitonin, and D-dimer showed a significant association with the mortality of patients with specificity and sensitivity more than 60%. Age, sex, underlying diseases, blood oxygen pressure, complete blood count along with C-reactive protein, lactic dehydrogenase, procalcitonin, D-dimer, and interleukin-6 evaluation help to predict the severity and required management for COVID-19 patients. Further investigations are highly recommended in a larger cohort study for validation of the present findings.
    Keywords Biomarkers ; COVID-19 ; Immunology ; Inflammation ; SARS-CoV-2 ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2021-02-01T00:00:00Z
    Publisher Tehran University of Medical Sciences
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top